Literature DB >> 15505157

Altered cortical visual processing in PD with hallucinations: an fMRI study.

G T Stebbins1, C G Goetz, M C Carrillo, K J Bangen, D A Turner, G H Glover, J D E Gabrieli.   

Abstract

OBJECTIVE: To compare fMRI activation during two visual stimulation paradigms in Parkinson disease (PD) subjects with chronic visual hallucinations vs PD patients who had never hallucinated.
METHODS: Twelve pairs of PD subjects, matched for age, PD duration, and dopaminergic drug exposure duration, participated in this study. The authors examined group differences in activation during stroboscopic (flashing) vs no visual stimulation and kinematic (apparent motion) vs stationary visual stimulation.
RESULTS: During stroboscopic stimulation, non-hallucinating PD subjects showed significantly greater activation in the parietal lobe and cingulate gyrus compared to hallucinating PD subjects. In contrast, the hallucinating subjects showed significantly greater activation in the inferior frontal gyrus and the caudate nucleus. During kinematic stimulation, non-hallucinating PD subjects showed significantly greater activation in area V5/MT, parietal lobe, and cingulate gyrus compared to hallucinating PD subjects. Hallucinating PD subjects showed significantly greater activation in the superior frontal gyrus.
CONCLUSIONS: PD patients with chronic visual hallucinations respond to visual stimuli with greater frontal and subcortical activation and less visual cortical activation than non-hallucinating PD subjects. Shifting visual circuitry from posterior to anterior regions associated primarily with attention processes suggests altered network organization may play a role in the pathophysiology of visual hallucinations in PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505157     DOI: 10.1212/01.wnl.0000141853.27081.bd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

Review 1.  An update expert opinion on management and research strategies in Parkinson's disease psychosis.

Authors:  Jennifer G Goldman; Christina L Vaughan; Christopher G Goetz
Journal:  Expert Opin Pharmacother       Date:  2011-06-02       Impact factor: 3.889

Review 2.  Biomarkers for cognitive impairment in Parkinson disease.

Authors:  Min Shi; Bertrand R Huber; Jing Zhang
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

3.  Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder.

Authors:  Maiya R Geddes; Yanmei Tie; John D E Gabrieli; Scott M McGinnis; Alexandra J Golby; Susan Whitfield-Gabrieli
Journal:  Cortex       Date:  2015-11-05       Impact factor: 4.027

Review 4.  Diagnosing schizophrenia circa 2005: how and why?

Authors:  Laurie M McCormick; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

5.  The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease.

Authors:  James M Shine; Glenda M Halliday; Moran Gilat; Elie Matar; Samuel J Bolitho; Maria Carlos; Sharon L Naismith; Simon J G Lewis
Journal:  Hum Brain Mapp       Date:  2013-06-13       Impact factor: 5.038

Review 6.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

7.  Dopamine Activation Preserves Visual Motion Perception Despite Noise Interference of Human V5/MT.

Authors:  Nada Yousif; Richard Z Fu; Bilal Abou-El-Ela Bourquin; Vamsee Bhrugubanda; Simon R Schultz; Barry M Seemungal
Journal:  J Neurosci       Date:  2016-09-07       Impact factor: 6.167

8.  Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia.

Authors:  Judith M Ford; Vanessa A Palzes; Brian J Roach; Steven G Potkin; Theo G M van Erp; Jessica A Turner; Bryon A Mueller; Vincent D Calhoun; Jim Voyvodic; Aysenil Belger; Juan Bustillo; Jatin G Vaidya; Adrian Preda; Sarah C McEwen; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2014-03-11       Impact factor: 9.306

Review 9.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 10.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.